Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3599.3000 -7.40 (-0.21%)
NSE Sep 04, 2025 15:31 PM
Volume: 128.4K
 

3599.30
-0.21%
Axis Direct
Torrent Pharma (TRP IN) reported decent performance in Q1FY20, with revenue stood at Rs 2,022Cr (vs estimate of Rs 2,017 Cr), which is largely in-line with our estimate. EBITDA at Rs541Cr (estimate of Rs521Cr) and EBITDA margins stood at 26.8% (expanded by ~127bps QoQ).
Sharekhan decreased Buy price target of Torrent Pharmaceuticals Ltd. to 4024.0 on 29 Aug, 2025.
More from Torrent Pharmaceuticals Ltd.
Recommended